This Slide: #69 of 100 |
Slide #69. BioScrip — CarePoint Partners Home Infusion Business
Acquirer:
BioScrip (NASDAQ:BIOS)
Acquiree:
CarePoint Partners Home Infusion Business
Details:
BioScrip, Inc. (NASDAQ: BIOS) today announced that it has entered into a definitive agreement to acquire the business of CarePoint Partners Holdings LLC and its subsidiaries (collectively, "CarePoint Partners") for $223 million in cash, subject to certain adjustments. CarePoint Partners is a leading national provider of home and alternate-site infusion therapy for patients with complex, acute and chronic illnesses. BioScrip also expects to realize the value of a future tax benefit estimated at $45 million as a result of the transaction, yielding a net purchase price of $178 million.
BioPlus Acquisition is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.
Open the BIOS Page at The Online Investor »
|
Open the BIOS Page at The Online Investor (in a new window) »
Free BIOS Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Strong Buy (4.00 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data; powered by Xignite |